BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19952482)

  • 1. Autoimmune pancreatitis associated with various extrapancreatic lesions during a long-term clinical course successfully treated with azathioprine and corticosteroid maintenance therapy.
    Naitoh I; Nakazawa T; Ohara H; Sano H; Ando T; Hayashi K; Tanaka H; Okumura F; Miyabe K; Yoshida M; Takahashi S; Joh T
    Intern Med; 2009; 48(23):2003-7. PubMed ID: 19952482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic extrapancreatic lesions associated with autoimmune pancreatitis.
    Ohara H; Nakazawa T; Sano H; Ando T; Okamoto T; Takada H; Hayashi K; Kitajima Y; Nakao H; Joh T
    Pancreas; 2005 Oct; 31(3):232-7. PubMed ID: 16163054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum IgG4 levels and extrapancreatic lesions in autoimmune pancreatitis.
    Kamisawa T; Imai M; Egawa N; Tsuruta K; Okamoto A
    Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1167-70. PubMed ID: 18936710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of extrapancreatic lesions in autoimmune pancreatitis.
    Naitoh I; Nakazawa T; Ohara H; Ando T; Hayashi K; Tanaka H; Okumura F; Miyabe K; Yoshida M; Sano H; Takada H; Joh T
    Pancreas; 2010 Jan; 39(1):e1-5. PubMed ID: 19924018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune pancreatitis and IgG4-related sclerosing cholangitis.
    Takuma K; Kamisawa T; Igarashi Y
    Curr Opin Rheumatol; 2011 Jan; 23(1):80-7. PubMed ID: 21124090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metachronous extrapancreatic lesions in autoimmune pancreatitis.
    Takuma K; Kamisawa T; Anjiki H; Egawa N; Igarashi Y
    Intern Med; 2010; 49(6):529-33. PubMed ID: 20228586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune pancreatitis and IgG4-associated sclerosing cholangitis.
    Nishimori I; Otsuki M
    Best Pract Res Clin Gastroenterol; 2009; 23(1):11-23. PubMed ID: 19258183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic strategy for autoimmune pancreatitis.
    Kamisawa T; Satake K
    Adv Med Sci; 2008; 53(2):145-8. PubMed ID: 18762470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual field deficit: a rare initial symptom of autoimmune pancreatitis.
    Takuma K; Kamisawa T; Tabata T; Inaba Y; Egawa N; Ozaki N; Horiguchi S; Takuma S
    Intern Med; 2011; 50(8):887-91. PubMed ID: 21498937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune Pancreatitis: An Update on Diagnosis and Management.
    Madhani K; Farrell JJ
    Gastroenterol Clin North Am; 2016 Mar; 45(1):29-43. PubMed ID: 26895679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapse rate and predictors of relapse in a large single center cohort of type 1 autoimmune pancreatitis: long-term follow-up results after steroid therapy with short-duration maintenance treatment.
    Lee HW; Moon SH; Kim MH; Cho DH; Jun JH; Nam K; Song TJ; Park DH; Lee SS; Seo DW; Lee SK
    J Gastroenterol; 2018 Aug; 53(8):967-977. PubMed ID: 29362937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appropriate steroid therapy for autoimmune pancreatitis based on long-term outcome.
    Kamisawa T; Okamoto A; Wakabayashi T; Watanabe H; Sawabu N
    Scand J Gastroenterol; 2008; 43(5):609-13. PubMed ID: 18415756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of swollen duodenal papilla in autoimmune pancreatitis.
    Kubota K; Iida H; Fujisawa T; Ogawa M; Inamori M; Saito S; Kakuta Y; Oshiro H; Nakajima A
    Pancreas; 2007 Nov; 35(4):e51-60. PubMed ID: 18090232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management strategies for autoimmune pancreatitis.
    Kamisawa T; Takuma K; Hara S; Tabata T; Kuruma S; Inaba Y; Gopalakrishna R; Egawa N; Itokawa F; Itoi T
    Expert Opin Pharmacother; 2011 Oct; 12(14):2149-59. PubMed ID: 21711086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid Therapy and Steroid Response in Autoimmune Pancreatitis.
    Matsubayashi H; Ishiwatari H; Imai K; Kishida Y; Ito S; Hotta K; Yabuuchi Y; Yoshida M; Kakushima N; Takizawa K; Kawata N; Ono H
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune pancreatitis: a systemic immune complex mediated disease.
    Deshpande V; Chicano S; Finkelberg D; Selig MK; Mino-Kenudson M; Brugge WR; Colvin RB; Lauwers GY
    Am J Surg Pathol; 2006 Dec; 30(12):1537-45. PubMed ID: 17122509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis.
    Sandanayake NS; Church NI; Chapman MH; Johnson GJ; Dhar DK; Amin Z; Deheragoda MG; Novelli M; Winstanley A; Rodriguez-Justo M; Hatfield AR; Pereira SP; Webster GJ
    Clin Gastroenterol Hepatol; 2009 Oct; 7(10):1089-96. PubMed ID: 19345283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG4-related sclerosing disease: autoimmune pancreatitis and extrapancreatic manifestations.
    Vlachou PA; Khalili K; Jang HJ; Fischer S; Hirschfield GM; Kim TK
    Radiographics; 2011; 31(5):1379-402. PubMed ID: 21918050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune pancreatitis: pancreatic and extrapancreatic MR imaging-MR cholangiopancreatography findings at diagnosis, after steroid therapy, and at recurrence.
    Manfredi R; Frulloni L; Mantovani W; Bonatti M; Graziani R; Pozzi Mucelli R
    Radiology; 2011 Aug; 260(2):428-36. PubMed ID: 21613442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal autoimmune pancreatitis and chronic sclerosing sialadenitis mimicking pancreatic cancer and neck metastasis.
    Sun L; Zhou Q; Brigstock DR; Yan S; Xiu M; Piao RL; Gao YH; Gao RP
    World J Gastroenterol; 2014 Dec; 20(46):17674-9. PubMed ID: 25516685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.